|
Market Cap (25-Jun) $125,067,280 (1,258th) |
Close (30-Jun) $0.007 |
Volume (30-Jun) 188,484 |
Shortsold (14-May) 14,985,846 (0.14%) (426th) |
|
52w High $0.85 |
52w Low $0.350 |
P/E 10.33 |
EPS -0.07 |
ATH released this announcement to the ASX on 3 September 2021, 10:17. The announcement is marked as price sensitive, and is 139 page(s) in length and 776.23kb in size.
You can view all announcements from ATH and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATH was 0.036% short sold according to ASIC data. It was ranked the 508th most shorted stock on the ASX. It is now ranked as the 426th most shorted stock on the ASX with 0.138% of total shares short sold as of the latest reported data (14 May 2026).
| Other Recent Announcements from ATH | |
|---|---|
| Investor Presentation | 22 June 2023, 11:13 |
| ATH to present at MST Rare Diseases Rich Returns Forum | 21 June 2023, 9:52 |
| ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder | 30 May 2023, 13:32 |
| Form 20-F | 3 September 2021, 10:17 |
| ATH filed Form 20-F and XBRL data with SEC | 3 September 2021, 9:29 |
| Change in substantial holding | 1 September 2021, 8:17 |
| Appendix 4G and Corporate Governance Statement 2021 | 1 September 2021, 8:12 |
You must be logged in to post a reply.
Alterity Therapeutics 